Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

VLADAN P MILOSAVLJEVIC

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1982691655
CMS profile
135768
Location
LAWRENCE, MA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$13,121.76

254 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Page 3 of 6; records 101–150 of 254 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

VLADAN P MILOSAVLJEVIC

NPI 1982691655 · CMS profile ID 135768

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

LAWRENCE, MA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 6; records 101–150 of 254 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1982691655?year=2021&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
VLADAN P MILOSAVLJEVIC, NPI 1982691655, CMS profile ID 135768. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 6; records 101–150 of 254 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1982691655?year=2021&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). VLADAN P MILOSAVLJEVIC, NPI 1982691655, CMS profile ID 135768. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 6; records 101–150 of 254 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1982691655?year=2021&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
VLADAN P MILOSAVLJEVIC, NPI 1982691655, CMS profile ID 135768, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 6; records 101–150 of 254 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1982691655?year=2021&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

254 matching records · $13,121.76 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 254 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 254.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AbbVie Inc. $19.2707/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795699209 CMS
Biohaven Pharmaceuticals, Inc. $12.7407/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852568315 CMS
Avanir Pharmaceuticals, Inc. $1.0307/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 801023001 CMS
Avanir Pharmaceuticals, Inc. $16.0307/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 801023003 CMS
Janssen Pharmaceuticals, Inc $11.5907/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788891425 CMS
Janssen Pharmaceuticals, Inc $3.2507/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788891427 CMS
Janssen Pharmaceuticals, Inc $16.0507/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788891437 CMS
Biogen, Inc. $2.5307/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827794073 CMS
Biogen, Inc. $13.9007/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827794077 CMS
Biogen, Inc. $1.9807/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827794081 CMS
Biogen, Inc. $3.5007/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827794091 CMS
Biohaven Pharmaceuticals, Inc. $22.6907/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852568313 CMS
Avanir Pharmaceuticals, Inc. $3.4407/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 801025433 CMS
Biohaven Pharmaceuticals, Inc. $6.0807/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852568311 CMS
Biogen, Inc. $8.2907/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827794085 CMS
AbbVie Inc. $7.9107/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795699191 CMS
Celgene Corporation $14.2507/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783729103 CMS
UCB, Inc. $17.7007/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 807362867 CMS
Biohaven Pharmaceuticals, Inc. $24.6907/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852568309 CMS
Teva Pharmaceuticals USA, Inc. $1.5206/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 839589039 CMS
Teva Pharmaceuticals USA, Inc. $11.0506/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 839589041 CMS
MDD US Operations, LLC $18.1706/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 853057883 CMS
Avanir Pharmaceuticals, Inc. $3.8406/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 801027517 CMS
Avanir Pharmaceuticals, Inc. $13.8506/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 801027513 CMS
Avanir Pharmaceuticals, Inc. $1.4206/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 801027515 CMS
Biohaven Pharmaceuticals, Inc. $2.8606/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852568307 CMS
AbbVie Inc. $6.5706/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795699185 CMS
Celgene Corporation $114.0606/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783729137 CMS
GENZYME CORPORATION $22.0206/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843474499 CMS
Mallinckrodt Hospital Products Inc. $18.0406/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845369873 CMS
SK Life Science, Inc. $20.6206/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826822775 CMS
AbbVie Inc. $7.7906/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795699179 CMS
LivaNova USA, Inc. $102.8906/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 844254235 CMS
Biohaven Pharmaceuticals, Inc. $20.2606/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852568305 CMS
Teva Pharmaceuticals USA, Inc. $90.4906/16/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 839588973 CMS
Biogen, Inc. $17.2506/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827794107 CMS
Biogen, Inc. $2.1206/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827794111 CMS
Kyowa Kirin, Inc. $17.8306/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852989353 CMS
Kyowa Kirin, Inc. $5.3206/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852989355 CMS
Kyowa Kirin, Inc. $2.2506/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852989357 CMS
Biogen, Inc. $23.8306/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827794070 CMS
Janssen Pharmaceuticals, Inc $21.6606/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788891431 CMS
Janssen Pharmaceuticals, Inc $5.0006/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788891435 CMS
Neurocrine Biosciences, Inc. $12.8606/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 837805957 CMS
EMD Serono, Inc. $35.9606/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 849193465 CMS
EMD Serono, Inc. $4.0106/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 849193469 CMS
Sunovion Pharmaceuticals Inc. $21.0606/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821626365 CMS
Teva Pharmaceuticals USA, Inc. $3.8105/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 839589033 CMS
Teva Pharmaceuticals USA, Inc. $5.0905/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 839589035 CMS
Teva Pharmaceuticals USA, Inc. $6.6005/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 839589037 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $5,849.06 300
PY2020 $12,128.51 101
PY2021 $13,121.76 254
PY2022 $20,465.68 258
PY2023 $19,896.15 230
PY2024 $25,149.80 241
PY2025 $31,936.71 145

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2021 Principal investigator $54,778.50 10
PY2020 Principal investigator $11,935.00 2

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

10 records in PY2021

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 EMD Serono, Inc. $7,438.50 12/15/2021 Non-covered Recipient Entity
ActivMed Practices and Research LLC
A Phase III, Multicenter, Randomized, ParallelGroup, Double Blind, Double Dummy, ActiveControlled Study of Evobrutinib Compared withTeriflunomide, in Participants with RelapsingMultiple Sclerosis to Evaluate Efficacy and Safety No dispute reported 06/30/2026 842920879
Principal investigator 1 EMD Serono, Inc. $6,728.85 12/10/2021 Non-covered Recipient Entity
ActivMed Practices and Research LLC
A Phase III, Multicenter, Randomized, ParallelGroup, Double Blind, Double Dummy, ActiveControlled Study of Evobrutinib Compared withTeriflunomide, in Participants with RelapsingMultiple Sclerosis to Evaluate Efficacy and Safety No dispute reported 06/30/2026 842922009
Principal investigator 1 EMD Serono, Inc. $1,843.95 09/15/2021 Non-covered Recipient Entity
ActivMed Practices and Research LLC
A Phase III, Multicenter, Randomized, ParallelGroup, Double Blind, Double Dummy, ActiveControlled Study of Evobrutinib Compared withTeriflunomide, in Participants with RelapsingMultiple Sclerosis to Evaluate Efficacy and Safety No dispute reported 06/30/2026 842911853
Principal investigator 1 EMD Serono, Inc. $7,340.65 07/09/2021 Non-covered Recipient Entity
ActivMed Practices & Research LLC
A Phase III, Multicenter, Randomized, ParallelGroup, Double Blind, Double Dummy, ActiveControlled Study of Evobrutinib Compared withTeriflunomide, in Participants with RelapsingMultiple Sclerosis to Evaluate Efficacy and Safety No dispute reported 06/30/2026 842911759
Principal investigator 1 EMD Serono, Inc. $3,687.90 06/11/2021 Non-covered Recipient Entity
ActivMed Practices & Research LLC
A Phase III, Multicenter, Randomized, ParallelGroup, Double Blind, Double Dummy, ActiveControlled Study of Evobrutinib Compared withTeriflunomide, in Participants with RelapsingMultiple Sclerosis to Evaluate Efficacy and Safety No dispute reported 06/30/2026 842923079
Principal investigator 1 EMD Serono, Inc. $3,687.90 05/07/2021 Non-covered Recipient Entity
ActivMed Practices & Research LLC
A Phase III, Multicenter, Randomized, ParallelGroup, Double Blind, Double Dummy, ActiveControlled Study of Evobrutinib Compared withTeriflunomide, in Participants with RelapsingMultiple Sclerosis to Evaluate Efficacy and Safety No dispute reported 06/30/2026 842924717
Principal investigator 1 EMD Serono, Inc. $6,985.35 04/07/2021 Non-covered Recipient Entity
ActivMed Practices & Research LLC
A Phase III, Multicenter, Randomized, ParallelGroup, Double Blind, Double Dummy, ActiveControlled Study of Evobrutinib Compared withTeriflunomide, in Participants with RelapsingMultiple Sclerosis to Evaluate Efficacy and Safety No dispute reported 06/30/2026 842922765
Principal investigator 1 EMD Serono, Inc. $385.00 03/19/2021 Non-covered Recipient Entity
ActivMed Practices & Research LLC
A Phase III, Multicenter, Randomized, ParallelGroup, Double Blind, Double Dummy, ActiveControlled Study of Evobrutinib Compared withTeriflunomide, in Participants with RelapsingMultiple Sclerosis to Evaluate Efficacy and Safety No dispute reported 06/30/2026 842901971
Principal investigator 1 EMD Serono, Inc. $139.00 03/19/2021 Non-covered Recipient Entity
ActivMed Practices & Research LLC
A Phase III, Multicenter, Randomized, ParallelGroup, Double Blind, Double Dummy, ActiveControlled Study of Evobrutinib Compared withTeriflunomide, in Participants with RelapsingMultiple Sclerosis to Evaluate Efficacy and Safety No dispute reported 06/30/2026 842902217
Principal investigator 1 EMD Serono, Inc. $16,541.40 03/03/2021 Non-covered Recipient Entity
ActivMed Practices & Research LLC
A Phase III, Multicenter, Randomized, ParallelGroup, Double Blind, Double Dummy, ActiveControlled Study of Evobrutinib Compared withTeriflunomide, in Participants with RelapsingMultiple Sclerosis to Evaluate Efficacy and Safety No dispute reported 06/30/2026 842902041